| Total Score | People Score | Events Score |
|---|---|---|
| 8 | 8 | 6 |
| Date | Event | Presentation | Speakers |
|---|---|---|---|
| September 9, 2013 | 6th CNS Partnering and Deal Making Conference | Panel Discussion: Current and Future Trends in CNS Development | Mary Martinson |
| April 6, 2013 | AACR Annual Meetings | From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA | Dashyant Dhanak |
| From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 4: Oncology Drug Discovery and Development: Combination Therapies Chairperson: Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC | Tona M Gilmer, Axel Hoos | ||
| September 3, 2012 | Ourense Conference on Imaging Mass Spectrometry | Observing Directly the Distribution of an Inhaled Domain Antibody in Healthy and Infected Mice by MALDI MS Imaging | Peter S. Marshall |
| January 5, 2009 | High Content Analysis | Primary HCS for Immunomodulation | Carmel B Nanthakumar |
| February 19, 2008 | Screening Europe | Track B The Industrialisation of 1536 Well Format High Throughput Screening for Modulators of G Protein-Coupled Receptors | Stuart Baddeley |
| September 24, 2007 | High-Content Analysis Europe: High content Cellular Assays for compound screening and Pahtway Analysis (Sep 24-26) | HCA for Mechanism-of-Action Studies: Use of the BD Pathway in CNS Drug Discovery to Determine Mechanisms of Compound Action in Primary Neuronal Cultures (16:00-16:30) | Claire Scott |
| HCA for Mechanism-of-Action Studies (16:00-18:00) | Claire Scott |
How We Rank